Global Isothermic Nucleic Acid Amplification Technology (INAAT) Market Report 2021, Industry Analysis, Growth Rate and Forecast 2026

Isothermal nucleic acid market growth technology showed strong growth during 2015-2020. The market is expected to grow at a CAGR of around 10% during the forecast period (2021-2026), according to a new report from the IMARC Group.

Isothermal Nucleic Acid Proliferation Technology (INAAT) for the detection and analysis of nucleic acids is brought to the research department. It is used for DNA, RNA, protein cells, ions, molecules, etc. INAAT provides fast, accurate, and precise analysis of genetic material, as well as infectious diseases. Provides amplicons for the production of various nucleic acids commonly used in biosensing, bioimaging, and biomedicine. In addition, INAAT is also used to diagnose many diseases, such as influenza, HIV, tuberculosis, chlamydia, and gonorrhea (CT / NG), hepatitis A and B, etc.

Types of marketing:

The spread of COVID-19 has led to a rapid transition from specialized laboratory equipment to INAAT for the detection of coronavirus. In addition, the high incidence of many chronic diseases has created the need for better diagnosis and treatment, which promotes the growth of the market. The increasing incidence of INAAT in genetically modified genetics (GMOs) is also driving the market. Many technological advances in the region have led to the development of recombinase polymerase amplification (RPA), single primer isothermal amplification (SPIA), and strand displacement amplification (SDA). Increased investment in R&D services is expected to boost INAAT’s sales in the coming years.

Market Segmentation by Technology:

Helicase-based enhancements (HDA)

Reaction enzyme (CLOSE)

Molecular Isothermal Performance Expansion (LAMP)

Declaration of Expansion (SDA)

Nucleic Acid System Statement (NASBA)

Information dissemination information system (TMA)

Definition of single isothermal primer (SPIA)

Market ranking by application:

Diagnosis

Hepatitis

CT / NG

HIV

Influenza

Others

Blood test

Others

Sales division by end-user:

Hospital

Laboratory

Laboratory

Others

Market segment by region:

North America

Pacific Asia

Europe

Latin America

The Middle East and Africa

About us

IMARC Group is a leading market research firm providing market research and management strategies around the world. We work with local and regional clients to determine their most valuable opportunities, address their most important issues, and transform their business.

IMARC’s information products include large-scale marketing, science, economics, and technology for business leaders and advanced pharmaceutical companies, companies, and technologies. Industry foresight and research for plant technologies, advanced materials, drugs, food and beverage, travel and tourism, nanotechnology, and newspaper design are at the forefront of industry expertise.